Grupo de Metástasis Cerebral

Inicio | Investigación e innovación | Programas Científicos | Programa de Oncología Molecular | Grupo de Metástasis Cerebral

«Este contenido se encuentra unicamente en inglés»

Becarios Post-doctorales

  • Neibla Priego

Becarios Pre-Doctorales

  • Laura Adriana Álvaro
  • Pedro García
  • Lucía Zhu

Técnicos de Laboratorio

  • Lourdes Osuna
  • Natalia Yebra

Brain metastasis is the most common neurological complication of cancer. When metastatic cells reach the brain, prognosis is poor given that available therapies (i.e. surgery and radiation) have limited benefits for patients and the disease inevitably progresses. The rise in the number of patients with brain metastasis is partially due to the increasing number of systemic therapies that work extra-cranial but not in the brain. In this scenario, cancer cells present at this highly demanding secondary site have additional time to evolve and develop into clinically detectable lesions. In the laboratory, we study why and how cells from different cancer types (breast cancer, lung cancer and melanoma) are able to access the brain, survive and colonise this vital organ. We dissect the biology of these processes in vivo using experimental models in order to challenge the current status of this unmet clinical need.